Free Republic

100% forced vax based on 0% reliable data We’re being hounded into forced vaccination on the basis of dodgy data, expensively ineffective mRNA drugs, obvious corruption, fake news about preferable management drugs and demographic jab extensions that fail every known and measured cost/benefit analysis. As voluntary “vaccination” stutters, it’s game on for Omicron the Omnipotent as the Trojan Totalitarian Horse gallops over the drawbridge. Austria has gone, Greece is going, the EU is ready and Macron has called a Conseil Constitutionelle in anticipation. The Slog asks what the Resistance can do now. Less than a fortnight into the opening performance...

The renowned French scientist and virologist Didier Raoult -- who promoted the hydroxychloroquine drug -- could lose his post as head of Marseille's infectious diseases institute after the head of the city’s hospital system said it was time to find a successor. Didier Raoult promoted the anti-malaria drug hydroxychloroquine as a cheap treatment for Covid-19 at a time when the method was also being advocated without evidence by former US president Donald Trump and his Brazilian counterpart Jair Bolsonaro.Several studies, including one by the World Health Organization, have found hydroxychloroquine ineffective in treating Covid-19.France banned use of the drug...

The French official agency for medications, that depends directly on France’s Health Minister Véran, has refused to temporary use approval for hydroxychloroquine to the Marseille University Hospital, headed by Professor Didier Raoult. According to the October 23 communiqué, “To date, the available data, which are very heterogeneous and uneven, do not allow us to predict a benefit from hydroxychloroquine, alone or in combination, for the treatment or prevention of Covid-19 disease. In this context and in view of the available safety data showing increased risks, in particular cardiovascular risks, it cannot be assumed that hydroxychloroquine has a favorable risk...

Mutant strains of COVID-19 that are more contagious, but less serious, have turned up in France, possibly explaining why Europe is reporting a spike in confirmed cases. The chief of a leading French research hospital revealed the discovery to French lawmakers last week, the Sunday Times of London reported. Microbiologist Didier Raoult, who heads IHU Méditerranée Infection in Marseilles, told senators that the hospital’s infectious disease experts found seven coronavirus mutations during an analysis of COVID-19 tests over the summer. One strain, Raoult theorized, was brought in by people coming from North Africa after France lifted its lockdown in June....

The controversial French professor who vigorously defended the anti-malaria drug hydroxychloroquine to help beat the coronavirus has been targeted by an ethics complaint that could see him face sanctions or barred from practising, a medical association said Thursday. The Marseille-based Didier Raoult is accused in the complaint by medical peers of spreading false information about the benefits of hydroxychloroquine. US and Brazilian presidents Donald Trump and Jair Bolsonaro seized upon Raoult's promotion of hydroxychloroquine and have trumpeted its benefits since the pandemic erupted. But the method and conclusions of Raoult's studies were challenged from the start by critics and other...

This Wednesday June 24, Dr Didier Raoult, the esteemed professor of infectious diseases at the IHU-Marseille, presented a shock testimony at a special commission, in the context of the “information mission about the impact and the consequences of the coronavirus epidemic, in all its dimensions,” by the French national assembly. Professor Raoult’s testimony seemed to be feared by the president of the commission, MP Brigitte Bourguignon, from President Macron’s ruling party, who warned that the audition was not to be a TV series or a popular tribunal. There were important aspects that were not covered in this testimony. For...

The much anticipated research on 3,737 COVID-19 patients by Professor Raoult and his team was published this June 25th, as a pre-proof, in the journal Travel Medicine and Infectious Disease. The article “Outcomes of 3,737 COVID-19 patients treated with hydroxychloroquine/azithromycin and other regimens in Marseille, France: A retrospective analysis” can be found online at: Interestingly, in his testimony yesterday, at the French National Assembly, Prof. Raoult indicated that the article was refused by The Lancet the very same week as the venerable publication accepted the fraudulent and now retracted article by Mehra et al. Note that this research encompasses...

French doctor and virologist Didier Raoult, whose use of malaria medication hydroxychloroquine at a treatment for Covid-19 has attracted worldwide attention and controversy, was to respond to questions of a parliamentary committee investigating France’s response to the epidemic. The inquiry of 32 lawmakers from different political parties was launched last month to “learn lessons” about France’s handling of the Covid-19 epidemic. After looking into face masks, the panel was to turn to hydroxychloroquine, a malaria medication championed as a treatment for Covid-19 by Raoult, who was to respond in late afternoon. “What we want to understand from Mr. Raoult is...

Hydroxychloroquine (HCQ) as a possible cure for COVID-19 was prohibited in France on May 27 because of a recent study published on May 22 by The Lancet. The study cast doubts on the safety of the drug, which it says has no positive effects on the health of patients who swallowed it after being infected by the Chinese coronavirus. It also claimed that mortality of hospitalized patients went up from over 9 percent of the control group to 23 percent of patients receiving the drug in combination with a macrolide antibiotic.(Article by Jeanne Smits republished from LifeSiteNews.com)Despite many issues...

The French government on Wednesday revoked a decree authorising hospitals to prescribe the controversial drug for Covid-19 patients after France’s public health watchdog warned against its use to treat the disease. The drug has been the subject of much debate in France, where “maverick” Professor Didier Raoult claimed in March to have successfully treated Covid-19 patients using a combination of hydroxychloroquine and azithromycin. However, doctors have questioned the value of Professor Raoult’s study, saying it was poorly designed and based on too small a sample to offer hard evidence of benefit.

The French doctor who identified a cure for the coronavirus that saw immediate results, is now being targeted and smeared by those who want to cash in on a different more expensive drug made by Gilead. Of course nothing is sacred anymore. The progressive socialist left has taken over everything. Since the advent of the China coronavirus, we discovered that even medicine and the medical community is now a corrupt and political industry. This past week the far left New York Times released a report where they belittled “eminent French microbiologist Didier Raoult” and his claims for a quick and...

Renowned French researcher and physician posted this study today from Spain that found those who were essential workers and were out working actually were less infected than those who were cooped up at home in lockdown.The lockdowns didn’t work as intended in Spain. Governement study about COVID-19 seroprevalence in Spain: among workers, those who had an "essential profession" and continued working were less infected than those staying at home. This should lead to a reflection on the role of general confinement. https://t.co/rMaFSLH8eR pic.twitter.com/4pvoTGPiaz— Didier Raoult (@raoult_didier) May 14, 2020 More… BREAKING COVID-19 antibody testing in Spain estimates ~5% infected-Those...

Despite the warnings around taking hydroxychloroquine to combat the symptoms of COVID-19, prescriptions in France have increased by as much as 7,000% in certain parts of the country since the pandemic began. As reported by La Provence, a study looking at the 466 million French prescriptions written since the pandemic began in France, show a huge spike in doctors prescribing the drug. In the last week of March, for instance, over 10,000 people were prescribed hydroxychloroquine in Marseille alone. In France and the U.S., the use of hydroxychloroquine has been fraught between those who think the risks are small enough...

The new study, of which the abstract was released today, was performed at IHU Méditerranée Infection, Marseille, France. A cohort of 1061 COVID-19 patients, treated for at least 3 days with the Hydroxychloroquine-Azithromycin (HCQ-AZ) combination and a follow-up of at least 9 days was investigated. Key findings are: No cardiac toxicity was observed.  A good clinical outcome and virological cure was obtained in 973 patients within 10 days (91.7%).  A poor outcome was observed for 46 patients (4.3%); 10 were transferred to intensive care units, 5 patients died (0.47%) (74-95 years old) and 31 required 10 days of hospitalization...

We’ve been talking about anti-malaria drug hydroxychloroquine for about three weeks now. However, U.S. health agencies like FDA and CDA, are still very cautious about the effectiveness and safety of the two drugs due to small trial size and lack of sufficient data. In France, the government caved to pressure from renowned Dr. Didier Raoult, who led the new additional study on 80 patients, results show a combination of Hydroxychloroquine and Azithromycin to be effective in treating COVID-19. Dr Didier Raoult, a professor of infectious diseases who works at La Timone hospital in Marseille, then declared in a video on...

On March 19, we published a story about a trial study conducted by French researchers which showed a combination of Hydroxychloroquine (plaquenil) and Azithromycin to be effective in the treatment of COVID-19 patients. The study, which was led by renowned Didier Raoult​ M.D/Ph.D, et. al in France, showed that 100% of patients that received a combination of the two anti-malaria drugs tested negative and were virologically cured within 6 days of treatment. The first preliminary trial involved a total of 36 COVID-19 patients. However, U.S. health agencies like FDA and CDA, are still very cautious about the effectiveness and safety...

Up-to-date stats of France COVID-19 metrics, regional metrics, and then the current patients in Dr. Didier Raoult's group of patients on the Hydroxychloroquine and Azythromycin regimen. Here are the statistics as of 3/27/2020: France: Cases: 524,384 Fatalities: 23,587 IHU Stats: Number of tests performed: 38,436 Number of patients APM / IHU tested: 14,101 Number of APM / IHU patients testing positive: 1,577 Fatalities: 11 Patients on Hydroxychloroquine / Azythromycin treatment: Cohort Number: 701 Fatalities (for those at least 3 days on treatment): 1

President Trump has turned to a French virologist with a history of criticizing climate science to offer the world hope amid the novel coronavirus pandemic. Last week, Trump tweeted that the combination of two medicines could dramatically alter the often deadly course of COVID-19. "HYDROXYCHLOROQUINE & AZITHROMYCIN, taken together, have a real chance to be one of the biggest game changers in the history of medicine," Trump wrote. He then cited a study published in the International Journal of Antimicrobial Agents that afforded little time for peer review. Trump's optimism comes from a small study of about 40 COVID-19 patients...

As the Wuhan coronavirus is ravaging countries across the globe, there may be some promising news on the horizon. According to Gregory Rigano, an advisor to Stanford University School of Medicine, a world renowned French researcher tested a promising COVID-19 treatment option with a drug that’s been around for decades and is typically used to treat malaria.  “As of this morning…a well-controlled peer reviewed study carried out by the most eminent infectious disease specialist in the world—Didier Raoult, MD, PhD—out of the south of France, in which he enrolled 40 patients…that showed a 100 percent cure rate against coronavirus," Rigano...

IHU Méditerranée Infection / @IHU_Marseille / Twitter The trial was completed by Professor Didier Raoult, based at infectious diseases institute, IHU Méditerranée Infection in Marseille A renowned research professor in France has reported successful results from a new treatment for Covid-19, with early tests suggesting it can stop the virus from being contagious in just six days. Professor Didier Raoult from infection hospital l'Institut Hospitalo-Universitaire (IHU) Méditerranée Infection in Marseille (Bouches-du-Rhône, Provence-Alpes-Côte d'Azur), published a video explaining the trials on Monday March 16.Professor Raoult is an infectious diseases specialist and head of the IHU Méditerranée Infection, who has been tasked...